What is the main difference between CACI International and Doximity in terms of business models?

CACI International provides government and defence IT services, cyber security, and intelligence solutions, focused on contract-based revenue with government clients. Doximity operates as a digital platform for healthcare professionals, monetising through software services and communications tools. One serves traditional government contracting, the other relies on a scalable tech platform with network effects in healthcare. Both generate revenue, but their end markets and sale cycles differ markedly.

How should I interpret ‘revenue growth’ for these two stocks?

Revenue growth measures the increase in sales year over year. For CACI, 12.64% growth in 2025 signals top-line expansion from government programmes and services. For Doximity, growing user engagement and revenue indicates expanding adoption of its medical professional platform. Both reflect demand trends, but revenue mix and cadence differ due to contract-based versus software-as-a-service dynamics.

What does profit margin tell me in this comparison?

Profit margin shows how much profit a company retains from each dollar of sales. CACI’s net margin around 5.7% suggests modest profitability relative to revenue scale. Doximity’s margin data isn’t provided here, but the contrast between a diversified services firm and a software platform often influences margins differently. Lower margins may reflect higher operating costs or investment phases.

How do analyst opinions affect the perceived risk of these stocks?

Analyst ‘Strong Buy’ ratings imply expectations of upside, subject to target price accuracy and market conditions. For CACI, targets imply potential upside of roughly 9% to over 13% within a year, indicating positive sentiment. For Doximity, lack of a stated rating in this context means less consensus guidance. Investors should consider both the rating and the rationale behind it.

What role do valuation metrics play in this comparison?

Valuation metrics, like price-to-earnings (P/E), help gauge whether a stock’s price reflects future profits. CACI’s P/E around 22–26 suggests a premium for a sizable government-focused portfolio, which could limit upside if profits stall. For Doximity, absent explicit P/E data here, you’d compare growth expectations, margins, and cash flow to assess whether the price adequately reflects its software growth.

How does debt influence risk in this pair?

CACI’s debt-to-equity around 69% signals leverage that could heighten risk in downturns or rising interest rates. Leverage can amplify returns in good times but pressurise margins when revenue growth slows. Doximity’s debt profile isn’t specified here, but software platforms typically carry different leverage dynamics. Assess how each company funds growth and its ability to service debt.

What market factors could impact both stocks together?

Both stocks can be influenced by broader macro cycles, but in different ways. Government spending and defence budgets affect CACI, with potential volatility tied to policy changes. Doximity is exposed to healthcare tech demand and digital advertising cycles. General market risk, interest rate moves, and tech sector sentiment can similarly affect both, though channels differ.

How do industry dynamics shape each company’s outlook?

CACI operates in a defence and intelligence contracting space with long-term, often multi-year programmes, leading to relatively predictable revenue but cycle sensitivity. Doximity competes in digital health and professional networking, facing rapid tech-driven disruption and competitive pressure from larger players. Both are influenced by regulatory, privacy, and compliance developments that can redefine market dynamics.

What should beginners look for when comparing these stocks on a page like this?

Look for the business model, growth drivers, profitability, and leverage; note the scale and stability of revenue streams. Compare valuation context, such as P/E and growth expectations, and consider market and regulatory risks described. Use the pro/cons lists to understand what might support or challenge each stock’s future performance.

Is there an educational disclaimer I should observe on this page?

Yes. This content is educational and neutral, summarising publicly available information. It does not constitute financial advice or a buy/sell recommendation. Readers should perform their own due diligence and consider seeking professional guidance before making investment decisions.

CACI vs Doximity

CACI International delivers IT services, intelligence analysis, and enterprise solutions to U.S. federal government agencies under long-term contracts, while Doximity operates a professional network and telehealth platform serving physicians who use it for clinical communication and digital hiring. Both companies generate high-margin recurring revenue from specialized professional audiences yet operate in entirely different regulatory and competitive environments. The CACI vs Doximity comparison helps readers see how a defense-IT contractor's government-budget dependency and contract renewal risk compare to a healthcare-network platform's ad and subscription revenue model and physician network moat.

CACI International delivers IT services, intelligence analysis, and enterprise solutions to U.S. federal government agencies under long-term contracts, while Doximity operates a professional network a...

Comparison Snapshot

Key Financial Metrics

CACI

Metric

DOCS

$11.63B

Market Cap

$4.28B

19.35%

Potential Profit

176.37%

Buy

Analyst Rating

Buy

Discover More Comparisons

CACI vs Manhattan Associates

CACI International provides IT, cyber, and intelligence services to defense and federal intelligence agencies, winning contracts that demand security clearances and institutional knowledge that take years to accumulate. Manhattan Associates builds supply chain and omnichannel commerce software for retailers and logistics operators running some of the world's most complex fulfillment networks. Both are high-quality, asset-light technology businesses with sticky customer relationships and consistent earnings growth. The CACI vs Manhattan Associates comparison digs into contract renewal visibility, organic growth rates, margin profiles, and which software or services franchise commands a more defensible multiple given the nature of customer switching costs.

CACI vs Duolingo

CACI International wins large U.S. government intelligence and defense IT contracts that run for years, generating reliable revenue with predictable margins, while Duolingo builds a freemium language learning app monetized through subscriptions and advertising. Both companies invest aggressively in technology to widen their competitive moats, but they serve completely different customers and operate under vastly different business models. The CACI vs Duolingo comparison draws a sharp line between a profitable defense contractor with steady government cash flows and a high-growth consumer app company trading on the promise of its expanding daily active user base.

CACI vs Procore

CACI International provides national security technology services and analytics to U.S. government agencies under long-term contracts that create earnings visibility even in volatile macro environments, while Procore Technologies sells cloud-based construction management software to a fragmented industry that's been slow to adopt digital workflows but is now moving quickly. Both companies grow by embedding deeply into the workflows of customers who find it painful to switch. The CACI vs Procore comparison analyzes contract structures, net revenue retention, and which software-driven business earns its growth premium more convincingly.

Investment Analysis

CACI

Pros

CACI International delivered strong revenue growth of 12.64% in 2025, reaching $8.63 billion, demonstrating solid top-line expansion.
Analyst consensus rates CACI as a 'Strong Buy' with price targets indicating potential upside of around 9% to over 13% within the next year.
The company maintains a diversified portfolio offering advanced cyber, intelligence, and IT solutions, supporting national security and government transformation.

Considerations

Despite revenue growth, CACI's net profit margin remains modest at around 5.7%, indicating potential pressure on profitability.
CACI carries a moderate debt-to-equity ratio of approximately 69%, which could pose leverage risks in volatile markets.
The stock's valuation, with a current P/E ratio near 22–26, might limit upside compared to risk, with some forecasts suggesting price volatility.

Doximity

DOCS

Pros

Doximity has rapidly grown as a leading digital platform connecting healthcare professionals, capitalising on telehealth and digital transformation trends.
Recent financial updates indicate expanding user engagement and revenue growth supported by strong demand in healthcare communications.
The company benefits from a niche, defensible market position with network effects and scalable software solutions tailored to medical professionals.

Considerations

Doximity faces regulatory uncertainties and evolving privacy standards in the healthcare sector, which could impact operations and growth.
The stock is subject to market volatility driven by healthcare sector economic cycles and sensitivity to changes in digital ad spending.
Competitive pressures from bigger tech companies expanding into digital health and professional networking could challenge Doximity's market share.

Related Market Insights

The Pentagon's Software Revolution: Why Defence Contractors Are Pivoting to Enterprise Deals

Explore the Pentagon's software revolution. The US Army's £10bn Palantir deal signals a shift to enterprise tech. Discover investment opportunities in defence software & AI.